Direct drug susceptibility test for tubercle bacilli by the sputum swab culture method

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 2, 2000, Pages 168-173

  Mathew, Sara ^a   Nair, N G K ^a   Radhakrishna, S ^a   Gangadharam, P R J ^b  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cetrimide; Direct; Drug susceptibility; Swab

Indexed keywords

ISONIAZID; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CULTURE MEDIUM; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SPUTUM ANALYSIS; TUBERCULOSIS;

ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; BACTERIOLOGICAL TECHNIQUES; CULTURE MEDIA; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; SPUTUM; STREPTOMYCIN;

EID: 0034052729     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Gangadharam P R J. Drug resistance in tuberculosis. In: L B Reichman, E S Hershfield, eds. Tuberculosis: a comprehensive international approach. New York: Marcel Dekker Inc, 1993: pp 293-328.
2. Canetti G, Fox W, Khomenko A, et al. Advances in the techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programs. Bull World Health Organ 1969; 41: 21-43.
3. Gangadharam P R J. Drug resistance in mycobacteria. Boca Raton, FL, USA: CRC Press, 1984: pp 55-110.
4. Heifets L B, Good R C. Current laboratory methods for the diagnosis of tuberculosis. In: B R Bloom, ed. Tuberculosis: pathogenesis, protection and control. Washington, USA: ASM Press, 1994: pp 85-110.
5. Kubica G P, Dye W E. Laboratory methods for clinical, and public health mycobacteriology. Public Health Service, No. 1547. Atlanta, GA: CDC, 1967.
6. Roberts G, Goodman N L, Heifets L B, et al. Evaluation of the BACTEC radiomtric method for recovery of mycobacteria and drug susceptibility testing of M. tuberculosis from acid-fast smear-positive specimens. J Clin Microbiol 1984; 18: 384-388.
7. Kawa D E, Pennell D R, Kubista L N, Schell R F. Development of a rapid method for determining the susceptibility of Mycobacterium tuberculosis to isoniazid using the Gen-Probe DNA hybridization system. Antimicrob Agents Chemother 1989; 33: 1000-1005.
8. Jacobs W R, Jr, Barletta R G, Udani R, et al. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science 1993; 260: 819-822.
9. Vestal A L. Procedures for the isolation and identification of mycobacteria DHEW Publication, No. 77-8230-115. Atlanta, GA, USA: CDC, 1977.
10. Devaki V, Mohan K, Gangadharam P R J. Direct sensitivity test for isoniazid. Indian J Med Res 1969; 57: 1006-1010.
11. Devaki V, Gangadharam P R J, Nair N G K. Direct test for determining sensitivity of M. tuberculosis to streptomycin. Indian J Med Res 1972; 60: 354-357.
12. Mathew S, Paramasivan C N, Rehman F, et al. A direct rifampicin sensitivity test for tubercle bacilli. Indian J Med Res 1995; 83: 1573-1578.
13. Mackay J P P. A direct isoniazid sensitivity test. Tubercle 1964; 45: 229-234.
14. Stewart S M, Burnet M E. The detection of streptomycin, PAS and isoniazid resistant tubercle bacilli by the direct method. Tubercle 1968; 49: 217-225.
15. Joseph S, Nair N G K, Gangadharam P R J. A sputum swab culture method for tubercle bacilli using cetrimide, compared with two other swab culture methods and the concentration culture method. Tubercle 1969; 50: 299-304.
16. Tuberculosis Chemotherapy Centre, Madras. A concurrent comparison of home and sanatorium treatment of pulmonary tuberculosis in South India. Bull World Health Organ 1960; 21: 51-144.
17. Holst E, Mitchison D A, Radhakrishna S. Examination of smears for tubercle bacilli. Indian J Med Res 1959; 47: 495-499.
18. Heifets L B. Drug susceptibility in the chemotherapy of mycobacterial infections. Boca Raton, FL, USA: CRC Press 1991: pp 89-121.
19. Frieden T R, Fujiwara P L, Washko R M. Tuberculosis in New York City: turning the tide. N Engl J Med 1995; 333: 229-233.
20. Iseman M D, Cohn D L, Sbarbaro J A. Directly observed treatment of tuberculosis; we can't afford not to try it. N Engl J Med 1993; 328: 576-178.
21. Indian Council of Medical Research First Drug Resistance Investigation. Prevalence of drug resistance in patients with pulmonary tuberculosis presenting for the first time with symptoms to the chest clinics in India. Part 1. Findings in urban clinics giving no history of previous chemotherapy. Indian J Med Res 1968; 56: 1617-1630.
22. Indian Council of Medical Research Second Drug Resistance Investigation. Prevalence of drug resistance in patients with pulmonary tuberculosis presenting for the first time with symptoms at chest clinics in India. Part 2. Findings in urban clinics among all patients with or without history of previous chemotherapy. Indian J Med Res 1969; 57: 823-835.
23. de Kantor I N, Laszlo A. Tuberculosis laboratory procedures for developing countries. In: Gangadharam P R J, Jenkins P A, eds. Mycobacteria. Vol.1: Basic Aspects. New York and London: Chapman & Hall, 1997: pp 351-390.